In the present study, we demonstrate, for the first time, that Spred2 plays an important role in regulating the development of diet-induced obesity, obesity-induced adipose tissue inflammation, and metabolic abnormalities, including fatty liver disease. The gene discussed is SPRED2; the disease is obesity due to melanocortin 4 receptor deficiency.